People · Operator
Named in public records as an officer, director or promoter · active 2010–2011 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ReVision Therapeutics, Inc. | — | Biotechnology | Seed | $3.4M | $22.2M | 2010 |
Nathan Mata at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nathan Mata on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Weber | 1 | 8 |
| Douglas Downs | 1 | 6 |
| Jay Lichter, Ph.D. | 1 | 5 |
| Kevin Kinsella | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.